Xylem Inc. $XYL Shares Sold by Triglav Investments D.O.O.

Triglav Investments D.O.O. trimmed its holdings in shares of Xylem Inc. (NYSE:XYL) by 62.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,482 shares of the industrial products company’s stock after selling 4,178 shares during the quarter. Triglav Investments D.O.O.’s holdings in Xylem were worth $297,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently added to or reduced their stakes in XYL. J. Safra Sarasin Holding AG grew its stake in shares of Xylem by 5.6% during the first quarter. J. Safra Sarasin Holding AG now owns 332,132 shares of the industrial products company’s stock worth $39,632,000 after acquiring an additional 17,640 shares during the last quarter. LGT Fund Management Co Ltd. increased its holdings in shares of Xylem by 25.0% during the first quarter. LGT Fund Management Co Ltd. now owns 20,038 shares of the industrial products company’s stock valued at $2,395,000 after acquiring an additional 4,011 shares in the last quarter. Global Assets Advisory LLC purchased a new position in shares of Xylem in the 1st quarter valued at approximately $40,000. UNIVEST FINANCIAL Corp acquired a new stake in Xylem in the 1st quarter worth approximately $908,000. Finally, Welch & Forbes LLC boosted its stake in Xylem by 3.0% in the 1st quarter. Welch & Forbes LLC now owns 413,855 shares of the industrial products company’s stock worth $49,456,000 after purchasing an additional 12,023 shares in the last quarter. 87.96% of the stock is owned by institutional investors and hedge funds.

Xylem Stock Performance

XYL opened at $121.26 on Monday. Xylem Inc. has a 12-month low of $105.29 and a 12-month high of $154.27. The company has a current ratio of 1.46, a quick ratio of 1.10 and a debt-to-equity ratio of 0.13. The firm has a market capitalization of $28.82 billion, a PE ratio of 30.16, a P/E/G ratio of 1.72 and a beta of 1.03. The firm has a 50 day moving average of $112.64 and a two-hundred day moving average of $123.94.

Xylem (NYSE:XYL) last announced its quarterly earnings data on Tuesday, April 28th. The industrial products company reported $1.12 EPS for the quarter, beating the consensus estimate of $1.09 by $0.03. The business had revenue of $2.12 billion during the quarter, compared to analysts’ expectations of $2.11 billion. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The business’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same period in the previous year, the business posted $1.03 EPS. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. On average, analysts anticipate that Xylem Inc. will post 5.51 EPS for the current year.

Xylem Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Thursday, May 28th were issued a $0.43 dividend. This represents a $1.72 annualized dividend and a yield of 1.4%. The ex-dividend date of this dividend was Thursday, May 28th. Xylem’s dividend payout ratio is presently 42.79%.

Analyst Upgrades and Downgrades

XYL has been the topic of a number of recent analyst reports. Barclays cut their price target on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 29th. CLSA upgraded shares of Xylem to a “hold” rating in a research note on Thursday, June 25th. Citigroup dropped their price objective on shares of Xylem from $174.00 to $168.00 and set a “buy” rating on the stock in a report on Wednesday, April 29th. UBS Group upped their target price on Xylem from $132.00 to $133.00 and gave the company a “neutral” rating in a research report on Wednesday, April 29th. Finally, Weiss Ratings lowered Xylem from a “hold (c+)” rating to a “hold (c)” rating in a research note on Friday, May 8th. Eight research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $153.54.

Insider Buying and Selling at Xylem

In other Xylem news, CAO Geri-Michelle Mcshane sold 4,269 shares of the stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $117.46, for a total transaction of $501,436.74. Following the sale, the chief accounting officer directly owned 3,605 shares of the company’s stock, valued at approximately $423,443.30. This trade represents a 54.22% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Jerome A. Peribere purchased 1,210 shares of the business’s stock in a transaction on Monday, May 4th. The shares were bought at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the transaction, the director directly owned 27,209 shares in the company, valued at $3,172,841.49. This trade represents a 4.65% increase in their position. The disclosure for this purchase is available in the SEC filing. 0.32% of the stock is currently owned by corporate insiders.

Xylem Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.